JOURNAL OF CONTROLLED RELEASE | 卷:255 |
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8 | |
Article | |
Monterrubio, Carles1,2  Paco, Sonia1,2  Olaciregui, Nagore G.1,2  Pascual-Pasto, Guillem1,2  Vila-Ubach, Monica1,2  Cuadrado-Vilanova, Maria1,2  Mar Ferrandiz, M.1,2  Castillo-Ecija, Helena1,2  Glisoni, Romina3  Kuplennik, Nataliya4  Jungbluth, Achim5  de Torres, Carmen1,2  Lavarino, Cinzia1,2  Cheung, Nai-Kong V.5  Mora, Jaume1,2  Sosnik, Alejandro4  Carcaboso, Angel M.1,2  | |
[1] Inst Recerca St Joan de Deu, Santa Rosa 39-57, Barcelona 08950, Spain | |
[2] Hosp St Joan de Deu, Dept Pediat Hematol & Oncol, Barcelona 08950, Spain | |
[3] Univ Buenos Aires, Fac Pharm & Biochem, Dept Pharmaceut Technol, CONICET, RA-1113 Buenos Aires, DF, Argentina | |
[4] Technion Israel Inst Technol, Dept Mat Sci & Engn, Lab Pharmaceut Nanomat Sci, IL-3200003 Haifa, Israel | |
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA | |
关键词: GD2-targeted nanoparticles; Intratumor drug distribution; Microdialysis; Tumor extracellular fluid; Neuroblastoma; Irinotecan/SN-38; PDX models; | |
DOI : 10.1016/j.jconrel.2017.04.016 | |
来源: Elsevier | |
【 摘 要 】
Neuroblastoma is a pediatric solid tumor with high expression of the tumor associated antigen disialoganglioside GD2. Despite initial response to induction therapy, nearly 50% of high-risk neuroblastomas recur because of chemoresistance. Here we encapsulated the topoisomerase-I inhibitor SN-38 in polymeric nanoparticles (NPs) surface-decorated with the anti-GD2 mouse mAb 3F8 at a mean density of seven antibody molecules per NP. The accumulation of drug-loaded NPs targeted with 3F8 versus with control antibody was monitored by microdialysis in patient-derived GD2-expressing neuroblastoma xenografts. We showed that the extent of tumor penetration by SN-38 was significantly higher in mice receiving the targeted nano-drug delivery system when compared to non-targeted system or free drug. This selective penetration of the tumor extracellular fluid translated into a strong anti-tumor effect prolonging survival of mice bearing GD2-high neuroblastomas in vivo.
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_j_jconrel_2017_04_016.pdf | 1794KB | download |